Is astute moneyman Andrew Kroger a buyer of CTE shares...or a seller?
Right now, he controls 40% of the capital. He had the option of building beyond 50% when second-ranking shareholder Cell Care decided to sell. But he chose not to.
He has another option - to faciliate a takeover by selling his stake to private equity or other acquisitive interests.
If he was to do that, I'd suggest he'd be wanting at least a $1 per share.
Clearly, Cryosite is emerging as a pivotal clinical trials and cold chain logistics player. It has intriguing prospects.
Ann: Becoming a substantial holder, page-4
Add CTE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.100(8.77%) |
Mkt cap ! $60.52M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.20 | $20.39K | 16.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3420 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 9580 | 1 |
View Market Depth
| Last trade - 14.25pm 28/06/2024 (20 minute delay) ? |
| CTE (ASX) Chart |